 SAN DIEGO, Calif. and CALGARY, AB, March 5, 2021 PRNewswire --- Oncolytics Biotech Inc. NASDAQ: ONCY TSX: ONC, currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that it has entered into an at-the-market ATM equity offering sales... 